|
|
|
|
||
Re: JEFF just out - On the Road W/ Mgmt -- Would Buy for HemeA and Robust Pipeline BUY $19 TP>>> " Did anybody note that it looks like Sanofi has treated 2 more Beta Thal subjects . So it is now clear they will have results from at least 3 subjects at ASH in December." Agreed. I would also say that ASH is shaping up to be a shock and awe event for SGMO. HemoA durability and BetaThal (plus, something on SCD?). Follow that with an update of IVPRP probably around JPM. The Winter of 19/20 will be exciting. |
return to message board, top of board |